News Filters

Ratings Neutral

Astrana Health updates 2025 guidance to $3.1B–$3.18B revenue as full risk contract timing shifts, highlights AI integration

Breaking news from global financial markets

1 day ago 1,250 5m

NextNav outlines commercialization progress and FCC engagement while extending AT&T partnership to 2028

Ratings

1 day ago 3,702

Universal Electronics outlines Q4 revenue guidance of $82M–$92M amid connected home growth and cost actions

Ratings

1 day ago 1,001

AMN projects Q4 revenue above $720M at midpoint as labor disruption drives near-term growth

Ratings

1 day ago 1,593

Sight Sciences raises 2025 revenue guidance to $76M-$78M while accelerating TearCare commercialization

Ratings

1 day ago 1,370

Why The Narrative Around Principal Financial Is Shifting After Recent Analyst and Sector Updates

Ratings

1 day ago 3,611

Abacus Global Management raises 2025 guidance to $84M while initiating dividend and buyback

Ratings

1 day ago 2,711

Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability

Ratings

1 day ago 3,564

Sensus Healthcare signals 300%+ SRT code reimbursement increase as Fair Deal Agreement treatments rise 20% amid global expansion

Ratings

1 day ago 2,369

MindMed outlines three pivotal Phase III data readouts for 2026 as enrollment accelerates and $242.8M financing strengthens balance sheet

Ratings

1 day ago 4,665

Buy Alibaba, Sell Meituan Pair Trade Thrives on Price War Bets

Ratings

1 day ago 887

Lamar expects $8.10–$8.20 AFFO per share for 2025 while projecting strong 2026 momentum backed by $300M in acquisitions

Ratings

1 day ago 2,219

Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption

Ratings

1 day ago 4,822

AvePoint outlines $1B ARR target for 2029 with expanded AI governance and SaaS momentum

Ratings

1 day ago 2,547

Blend Labs signals resilient platform momentum with Q4 revenue guidance at $31M-$32.5M amid strategic focus on AI and consumer banking expansion

Ratings

1 day ago 3,895

Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus

Ratings

1 day ago 2,532

Affirm signals 4% RLTC upper bound and extends Amazon partnership through 2031 while expanding 0% offerings

Ratings

1 day ago 2,171

Fox Factory updates Q4 2025 outlook with net sales guidance of $340M–$370M amid ongoing macro headwinds

Ratings

1 day ago 3,894

Seeking AI Exposure? Use This Zacks Tool

Ratings

1 day ago 4,424

Is Maersk Attractively Priced After Recent 3.9% Price Dip?

Ratings

1 day ago 2,459

Trending Now

RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shi...

8,837 36 minutes ago

Cathie Wood buys $13.8 million of tumbling tech stock

4,501 40 minutes ago

Tariffs Are Hurting DIY Car Mechanics, O'Reilly Auto Parts, AutoZone CEOs Say

1,208 46 minutes ago

Qualcomm earned $215 target from BofA: Here’s what could derail it

32,375 1 hour ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with...

1,158 1 hour ago

Sentiment (24h)

Positive

487

Neutral

165

Negative

157

Menu

News Filters

Astrana Health updates 2025 guidance to $3.1B–$3.18B revenue as full risk contract timing shifts, highlights AI integration

NextNav outlines commercialization progress and FCC engagement while extending AT&T partnership to 2028

Universal Electronics outlines Q4 revenue guidance of $82M–$92M amid connected home growth and cost actions

AMN projects Q4 revenue above $720M at midpoint as labor disruption drives near-term growth

Sight Sciences raises 2025 revenue guidance to $76M-$78M while accelerating TearCare commercialization

Why The Narrative Around Principal Financial Is Shifting After Recent Analyst and Sector Updates

Abacus Global Management raises 2025 guidance to $84M while initiating dividend and buyback

Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability

Sensus Healthcare signals 300%+ SRT code reimbursement increase as Fair Deal Agreement treatments rise 20% amid global expansion

MindMed outlines three pivotal Phase III data readouts for 2026 as enrollment accelerates and $242.8M financing strengthens balance sheet

Buy Alibaba, Sell Meituan Pair Trade Thrives on Price War Bets

Lamar expects $8.10–$8.20 AFFO per share for 2025 while projecting strong 2026 momentum backed by $300M in acquisitions

Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption

AvePoint outlines $1B ARR target for 2029 with expanded AI governance and SaaS momentum

Blend Labs signals resilient platform momentum with Q4 revenue guidance at $31M-$32.5M amid strategic focus on AI and consumer banking expansion

Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus

Affirm signals 4% RLTC upper bound and extends Amazon partnership through 2031 while expanding 0% offerings

Fox Factory updates Q4 2025 outlook with net sales guidance of $340M–$370M amid ongoing macro headwinds

Seeking AI Exposure? Use This Zacks Tool

Is Maersk Attractively Priced After Recent 3.9% Price Dip?

Trending Now

RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shi...

Cathie Wood buys $13.8 million of tumbling tech stock

Tariffs Are Hurting DIY Car Mechanics, O'Reilly Auto Parts, AutoZone CEOs Say

Qualcomm earned $215 target from BofA: Here’s what could derail it

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with...

Trending Topics

Sentiment (24h)

Menu

News Filters

Astrana Health updates 2025 guidance to $3.1B–$3.18B revenue as full risk contract timing shifts, highlights AI integration

NextNav outlines commercialization progress and FCC engagement while extending AT&amp;T partnership to 2028

Universal Electronics outlines Q4 revenue guidance of $82M–$92M amid connected home growth and cost actions

AMN projects Q4 revenue above $720M at midpoint as labor disruption drives near-term growth

Sight Sciences raises 2025 revenue guidance to $76M-$78M while accelerating TearCare commercialization

Why The Narrative Around Principal Financial Is Shifting After Recent Analyst and Sector Updates

Abacus Global Management raises 2025 guidance to $84M while initiating dividend and buyback

Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability

Sensus Healthcare signals 300%+ SRT code reimbursement increase as Fair Deal Agreement treatments rise 20% amid global expansion

MindMed outlines three pivotal Phase III data readouts for 2026 as enrollment accelerates and $242.8M financing strengthens balance sheet

Buy Alibaba, Sell Meituan Pair Trade Thrives on Price War Bets

Lamar expects $8.10–$8.20 AFFO per share for 2025 while projecting strong 2026 momentum backed by $300M in acquisitions

Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption

AvePoint outlines $1B ARR target for 2029 with expanded AI governance and SaaS momentum

Blend Labs signals resilient platform momentum with Q4 revenue guidance at $31M-$32.5M amid strategic focus on AI and consumer banking expansion

Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus

Affirm signals 4% RLTC upper bound and extends Amazon partnership through 2031 while expanding 0% offerings

Fox Factory updates Q4 2025 outlook with net sales guidance of $340M–$370M amid ongoing macro headwinds

Seeking AI Exposure? Use This Zacks Tool

Is Maersk Attractively Priced After Recent 3.9% Price Dip?

Trending Now

RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shi...

Cathie Wood buys $13.8 million of tumbling tech stock

Tariffs Are Hurting DIY Car Mechanics, O'Reilly Auto Parts, AutoZone CEOs Say

Qualcomm earned $215 target from BofA: Here’s what could derail it

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with...

Trending Topics

Sentiment (24h)

NextNav outlines commercialization progress and FCC engagement while extending AT&T partnership to 2028